Skip to main content
Log in

A Preclinical Study of the Safety and Efficacy of Occlusin™ 500 Artificial Embolization Device in Sheep

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Introduction

This study evaluated the safety, effectiveness, and biodegradation of a new embolic agent, Occlusin™ 503 Artificial Embolization Device (OCL 503). The agent consists of biodegradable poly-lactic-co-glycolic acid microspheres (150–212 μm) coated with type I bovine collagen and was compared with Embosphere® Microspheres (300–500 μm) in this controlled study of uterine artery embolization (UAE) in sheep.

Methods

Unilateral UAE was performed in 32 adult ewes randomly assigned. Vessels were embolized to effective stasis. The cohort was divided into four groups, which were sacrificed at 1, 3, 6, and 12 months.

Results

Both agents were 100% effective in achieving stasis. At 6 months, all OCL 503-treated arteries were occluded, the microspheres degraded with time, and at 12 months all four animals examined demonstrated recanalization. OCL 503 was found in the untreated uterine artery in one animal with no other evidence of non target embolization. In the Embosphere-treated group, all vessels remained occluded and microspheres were detected in the contralateral uterine artery in 6 of 15 examined vessels and in 10 vaginal, 2 ovarian, and 1 vesical artery. No procedural-related complications were seen in either group.

Conclusions

OCL 503 is as effective an embolic agent as Embosphere® Microspheres when embolizing ovine uterine arteries and resorbs with time, allowing recanalization of the treated arteries. No device-related issues or adverse events were observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Pelage J-P, Laurent A, Bonneau M et al (2001) Arterial blood supply to the uterus in nonpregnant sheep: a pertinent model for clinical practice? Investig Radiol 36:721–725

    Article  CAS  Google Scholar 

  2. Pelage J-P, Laurent A, Wassef M et al (2002) Uterine artery embolization in sheep: comparison of acute effects with polyvinyl alcohol particles and calibrated microspheres. Radiology 224:436–445

    Article  PubMed  Google Scholar 

  3. Laurent A, Wassef M, Namur J et al (2009) Recanalization and particle exclusion after embolization of uterine arteries in sheep: a long-term study. Fertil Steril 91:884–892

    Article  PubMed  Google Scholar 

  4. Brill A (2009) Treatment of fibroids via uterine artery occlusion uterine artery embolization and Doppler-guided uterine artery occlusion): potential role in today’s armamentarium. Arch Gynecol Obstet 280:513–520

    Article  PubMed  Google Scholar 

  5. Laurent A, Pelage J-P, Wassef M et al (2008) Fertility after bilateral uterine artery embolization in a sheep model. Fertil Steril 89:1371–1383

    Article  PubMed  Google Scholar 

  6. Vlahos L, Benakis V, Dimakakos P et al (1980) A comparative study of the degree of arterial recanalization in kidneys of dogs following transcatheter embolization with eight different materials. Eur Urol 6:180–185

    PubMed  CAS  Google Scholar 

  7. Geschwind J-F, Ramsey D, Cleffken B et al (2003) Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Interv Radiol 26:111–117

    Article  Google Scholar 

  8. Jander J, Russinovich N (1980) Transcatheter gelfoam embolization in abdominal, retroperitoneal, and pelvic hemorrhage. Radiology 136:337–344

    PubMed  CAS  Google Scholar 

  9. Chrisman H, Saker M, Yu R et al (2000) The impact of uterine fibroid embolization on resumption of menses and ovarian function. J Vasc Interv Radiol 11:699–703

    Article  PubMed  CAS  Google Scholar 

  10. Goodwin SC, McLucas B, Lee M et al (1999) Uterine artery embolization for the treatment of uterine leiomyomata mid-term results. J Vasc Interv Radiol 10:1159–1165

    Article  PubMed  CAS  Google Scholar 

  11. Spies JB, Scialli A, Jha RC et al (1999) Initial results from uterine fibroid embolization for symptomatic leiomyomata. J Vasc Interv Radiol 10:1145–1157

    Article  Google Scholar 

  12. Kim H, Tsai J, Lee J et al (2006) Effects of utero-ovarian anastomoses on basal follicle-stimulating hormone level change after uterine artery embolization with tris-acryl gelatin microspheres. J Vasc Interv Radiol 17:965–971

    Article  PubMed  Google Scholar 

  13. Marx M, Wack J, Baker E et al (2001) Ovarian protection by occlusion of uteroovarian collateral vessels before uterine fibroid embolization. J Vasc Interv Radiol 14:1329–1332

    Article  Google Scholar 

  14. Bilbao J, de Luis E, García de Jalón J et al (2008) Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation. J Vasc Interv Radiol 19:1625–1638

    Article  PubMed  Google Scholar 

  15. Senturk C, Cakir V, Yorukoglu K et al (2010) Looking for the ideal particle: an experimental embolization study. Cardiovasc Intervent Radiol 33:336–345

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Tracey Clare (RN) for her assistance in performing this study. This work was supported by an operating grant from ViRexx Medical Corp., Edmonton, AB, Canada.

Conflict of interest

Robert Polakowski, Jennifer A Biliske, Paul B Tiege, and Irwin J Griffith are former employees of ViTexx Medical Corp., which provided an operating grant that supported the study. Irwin J Griffith is a current employee of IMBiotechnologies Ltd. There are no other conflicts.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard J. Owen.

Additional information

This work was conducted at the University of Alberta, Edmonton, Ab, Canada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Owen, R.J., Nation, P.N., Polakowski, R. et al. A Preclinical Study of the Safety and Efficacy of Occlusin™ 500 Artificial Embolization Device in Sheep. Cardiovasc Intervent Radiol 35, 636–644 (2012). https://doi.org/10.1007/s00270-011-0218-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-011-0218-7

Keywords

Navigation